What is it about?
This study examines how α‑lipoic acid, in its oxidized form, activates the Nrf2 pathway in primary human umbilical vein endothelial cells. At nanomolar levels, oxidized α‑lipoic acid—but not its reduced form—prevents TNF‑α–induced dysfunction and inhibits NF‑κB activation. The work reframes α‑lipoic acid not as a classic electron‑donor antioxidant but as an electrophilic trigger of hormetic responses.
Featured Image
Photo by Paris Bilal on Unsplash
Why is it important?
Understanding how nutritional molecules regulate redox balance is essential for interpreting their biological impact. This study highlights that α‑lipoic acid may exert its protective effects by stimulating endogenous antioxidant systems rather than acting as a direct scavenger. This conceptual shift affects how we view supplements, redox biology, and cellular stress responses.
Perspectives
The findings are based on in vitro HUVEC models, so biological complexity and in vivo dynamics remain unresolved. The work invites reconsideration of past studies that assumed α‑lipoic acid acted primarily as a reducing antioxidant. Future research should explore dose‑dependence, electrophilicity, and hormesis across different cell types and physiological contexts.
Prof. Antonio Speciale
University of Messina
Read the Original
This page is a summary of: Alpha-lipoic acid, but not di-hydrolipoic acid, activates Nrf2 response in primary human umbilical-vein endothelial cells and protects against TNF-α induced endothelium dysfunction, Archives of Biochemistry and Biophysics, August 2018, Elsevier,
DOI: 10.1016/j.abb.2018.08.003.
You can read the full text:
Contributors
The following have contributed to this page
